Renzo's update was a game-changer. Local isotope production could be a real cost-saver and growth driver for OSL and the PANCOSIL trial is the breakthrough that OSL needed. Precision treatment in pancreatic cancer is the future, and we are in it. Excited to be here.
OncoSil AMG Resolutions, page-3
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.4¢ | 1.3¢ | $15.02K | 1.101M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 11004682 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 615300 | 4 |
View Market Depth
| Last trade - 10.27am 27/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |